Development and validation of an intra-tumoral and peri-tumoral radiomics model based on dynamic contrast-enhanced ultrasound for predicting lymph node metastasis in type 2 diabetic patients with thyroid cancer - Takeaways - MDSpire

Development and validation of an intra-tumoral and peri-tumoral radiomics model based on dynamic contrast-enhanced ultrasound for predicting lymph node metastasis in type 2 diabetic patients with thyroid cancer

  • By

  • Siyao Li

  • Yunzhi Zhou

  • Wanyan Li

  • Ansheng Liu

  • Yanjun Hu

  • Chaoxue Zhang

  • Yayang Duan

  • June 23, 2026

  • 0 min

Share

  • 1

    The study developed radiomics models using dynamic contrast-enhanced ultrasound to predict lymph node metastasis in diabetic thyroid cancer patients.

  • 2

    A total of 203 diabetic thyroid cancer patients were included, divided into training and validation cohorts for model assessment.

  • 3

    Key radiomics features were extracted from CEUS parameters, and the optimal peri-tumoral region was determined to enhance model performance.

  • 4

    The combined radiomics model achieved AUCs of 0.930, 0.907, and 0.865 across training and validation cohorts, indicating strong predictive capability.

  • 5

    Calibration curves showed good agreement between predicted and actual outcomes, highlighting the model's potential clinical utility.

Original Source(s)

Related Content